Creative Planning
IDXX icon

Creative Planning’s Idexx Laboratories IDXX Stock Holding History

Creative Planning’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$91K – 2013
2018
Q3 		$91K Hold
1,000
– – ﹤0.01% 1807
2018
Q2 		$51K Buy
+1,000
New +$206K ﹤0.01% 1849

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Creative Planning's IDXX Position: Q2 2026 in Review

Creative Planning increased its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, buying an estimated $3.56M and bringing the position to 43,512 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #459.

Creative Planning first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.5M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Creative Planning held 43,512 shares of Idexx Laboratories worth $22.9M as of Q2 2026.
  • Creative Planning bought 6,342 Idexx Laboratories shares in Q2 2026, an estimated $3.56M.
  • Idexx Laboratories made up 0.01% of Creative Planning's portfolio in Q2 2026, its #459 holding.
  • Creative Planning first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's Idexx Laboratories position peaked at $24.5M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.